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Summary
The rearrangement and expression of human T cell receptor (TCR)-y and -b gene segments
in clonal and polyclonal populations of early fetal and postnatal human TCR-7/6 thymocytes
were examined. The data suggest that the TCRy and -b loci rearrange in an ordered and coordinated
fashion. Initial rearrangements at the TCR-b locus join Vat to D63, and initial rearrangements
at the TCR-y locus join downstream Vy gene segments (Vyl.8 and VY2) to upstream JY gene
segments associated with Cyl. These rearrangements are characterized by minimal junctional
diversity. At later times there is a switch at the TCR-b locus such that V61 is joined to upstream
Da gene segments, and a switch at the TCRy locus such that upstream V., gene segments are
joined to downstream Jy gene segments associated with CY2. These rearrangements are
characterized by extensive junctional diversity. Programmed rearrangement explains in part the
origin ofdiscrete subpopulations ofperipheral blood TCRy/b lymphocytes that have been defined
in previous studies. In addition, cytokine production by earlyfetal and postnatal TCRy/b thymocyte
clones was examined. Fetal thymocyte clones produced significant levels of114 and IL -5 following
stimulation, whereas postnatal thymocyte clones did not produce these cytokines. Thus, these
cell populations may represent functionally distinct subsets as well.
revious studies of clonal and polyclonal human TCR-y/b
lymphocytes derived from peripheral blood have revealed
the presence of two major subpopulations based upon vari-
able (V) and constant (C) gene segment usage (1-11). The
majority of peripheral blood TCR yb lymphocytes bear
receptors using both V62 and Vy2 (Vy9 in the nomenclature
of Lefranc et al. [12]).' The TCR y and b chains of these
receptors are disulfide-linked, indicating that the TCR y chains
are encoded by Cy l rather than Cy2 (13, 14). A smaller
populationof peripheral blood TCR- y/S lymphocytes bear
receptors using V61. The majority of these lymphocytes use
members of the V.y1 gene family, rather than VY2, and the
TCR y and b chains of these receptors are frequently
non-disulfide linked, indicating that the TCR y chains are
' The nomenclature used for human Vy and Jy gene segments is
that of Strauss et al. (66). The relationship between this scheme and
that of Lefianc et al. (12, 67) is described in Ref. 63. The nomencla-
ture for human VS gene segments is that of Hata et al. (8) and
Takihara et al. (50), and for human DS and JS gene segments is that
of Loh et al. (47).
encoded by the Cy2 genesegment. The explanation for the
presence of relatively discrete populations of TCR-y/b lym-
phocytes is unclear.
Analysis of the ontogeny of murine TCR-y/b lympho-
cytes indicates that rearrangements at the TCR-y and -b loci
occurin an orderly fashion (15-19). The first detectable wave
of rearrangements in early fetal thymocytes involves the V.y32
and Vat gene segments. A distinct population of late fetal
thymocytes displays rearrangements of the Vy4 and V61 gene
segments. These early rearrangements are also characterized
by lowjunctional diversity, since there is minimal incorpora-
tion of template independent N region nucleotides, and only
the 3' D6 segment (D62) is used. Murine dendritic epidermal
y/b cells apparently originate from the early V .,3-V61 popu-
lation of fetal thymocytes, and mucosal intraepithelial lym-
phocytes apparently originate from the subsequent Vy4V61
population (20-22). Adult thymocytesdisplay rearrangements
s The nomenclature for murine Vy gene segments is that of Garman
et al. (15), and the relationship between this scheme and those of
others is described in Ref. 69.
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tensive junctional diversity (23, 24).
Based upon indirect evidence it has previously been sug-
gested that rearrangements within the human TCRy locus
may be ordered (25). It was proposed that the initial rear-
rangements at this locusjoin the downstream Vy gene seg-
ments (i.e., Vy2, Vy3, Vy4) to the upstream Jy gene seg-
ments (i.e., those associated with Cyl: Jy1.1, Jy l.2, Jy l.3),
whereas subsequent rearrangements join the upstream Vy
gene segments (i.e., members of the Vyl family) to the
downstream Jy gene segments (i.e., those associated with
Cy2: Jy2.1, Jy2.3). To date, this has not been confirmed by
the direct analysis of gene rearrangements in early human
fetal thymocytes. Further, no information is available con-
cerningthe sequence ofrearrangements at thehumanTCR-6
locus.
In this manuscript we have analyzed TCR-y and TCR6
gene rearrangement and expression in clonal and polyclonal
early fetal and postnatal human TCRy/b thymocytes. We
show directly that early TCR-y rearrangements join down-
stream V segments to upstream J segments, that these rear-
rangements occur coordinately with an early wave of Va2
rearrangements at the TCR6 locus, and that these early
TCRy and-6 gene rearrangements displaylimitedjunctional
diversity.
Since our analysis showed the TCRs expressed by early
fetal TCRy/b thymocytes to be distinct from those of post-
natalTCRy/b thymocytes, we asked whetherthesecell popu-
lations representfunctionally distinct subsetsas well. We found
that fetal TCR-y/b thymocyte clones were able to secrete
significant levels o£ I1r4 and ID5, whereas postnatal clones
did not secrete these cytokines. Both sets of clones produce
high levels of granulocyte/macrophage CSF (GM-CSF)3 and
IFN-y.
Materials and Methods
Establishment ofTCR-y/6Thymocyte Clones.
￿
Postnatalthymuses
were obtained from children undergoing corrective heart surgery
andwere kindly provided by Dr. D. Regal, Centra de Transfusion
Sanguine, Lyon, France. Fetal thymic material was obtained from
J. L. Touraine, Hopital Eduard Herriot, Lyon, France. Thymocyte
suspensions were prepared by gently teasing thymus tissue into a
single cell suspension. An entire lobule was used to ensure that
both cortical and medullarycellswere represented.Thefetalthymo-
cyte samples and the samples from child thymus OM were cul-
turedin a mixture of 20 U/ml 11,2 and 100 U/ml 11,4 for 10 d.
This procedureincreasedthenumber of TCRy/6cells from <1%
to 10% (OM), 5% (Solo),6% (BB),and 7% (CC). Thecellswere
then stained with anti TCR-S1, which recognizes an epitope on
the TCR 6 chain, and were washed and incubated with goat
anti-mouse-labeled human red blood cells. The TCRy/6* cells
were enriched as described previously (26). TCRy/6 cells of in-
dividual FH (4 mo old) were isolated from afreshthymocytesample
usingacombination of magneticbead and FRCS sorting as follows:
thymocytes were incubatedwith anti-CD4 (RIVE; kindlyprovided
by Dr. Kreeftenberg, RIV, Bilthoven, Netherlands) andanti-CD8
(WT82; a kind gift from Dr. W Tax, University of Nijmegen,
'Abbreviation used in this paper: GM-CSF, granulocyte/macrophage CSF.
Netherlands) mAbs for 30 min at 4°C, andwere washed and then
incubatedwith biotinylated goat anti-mouse antibody (Tago, Inc.,
Burlingame, CA) for 30 min. After washing, the cells were in-
cubated for 5 min with FITC-labeled avidin (Becton Dickinson
&Co., Mountain View, CA), and subsequently with biotinylated
magnetic beads. CD4* CD8* cells were then removed on a
MACS (27). Theremaining FITC-labeled cellswere then removed
by sorting on a FACStar plus (Becton Dickinson). 50% of the
depleted cell population stained with PE-labeled anti-CD3 (PE-
Len 4, Becton Dickinson) and <0.5% of the cells were CD4*
CD8* as indicated by reanalysis of the sorted cells. The CD4-
CD8- FH cells and the TCRy/6 enriched cultures of Solo, BB,
CC, andOM were cloned by limiting dilution at 0.3 cell perwell
in a96-well plate (Linbro, Flow Laboratories, McLean, VA)in the
presence of a feeder cell mixture consisting of 5 x 101/ml irradi-
ated (4,000 rad) PBL, 5 x 10`/ml irradiated (5,000 rad) cells of
the EBVtransformed Bcell line JY, and 0.1 Ag/mlpurified PHA
(Wellcome Diagnostics, Dartford, England). Yssel's medium (28)
wasused forall cell cultures. Theclones were expanded by weekly
stimulations with thefeeder cell mixture. 3 d after each stimula-
tion, the cultures were split and 20 U/ml rIlr2 was added. The
feeder cells deteriorated between day 2 and 4 and at day 5 or 6
no feeder cells were visible or detectable with mAbs specific for
Bcells, monocytes, or TCR-a/o (datanot shown). For molecular
analysis of V, and Va usage, bulk cultures of theenriched BB and
CC cellswere maintained by weekly stimulations with feeder cells
and PHA.
Monoclonal Antibodies and Immunofluorescence
￿
The antiTCR
y/6 mAb TCR-61 (29) was akind gift ofDr. M. Brenner (Dana
Farber Cancer Institute, Boston, MA); 6TCS1(30) was purchased
from T Cell Sciences Inc. (Boston, MA); and the mAbs BB3 (31)
andTiyA (32) andwere giftsfrom Drs. L. Moretta(Genova, Italy)
and T Hercend (Institute Gustave Roussy, Paris, France), respec-
tively. Characterization of theTCRy/6 T cell clones wascarried
out as describedpreviously (28).Twohundredthousand cells were
incubatedwith mAbfor30minat 4°C, washed, andthen incubated
with FITC labelled goat anti-mouse F(ab)2 fragments (Tago Inc.,
Burlingame, CA) for 30 min at 4°C. Cells were washed and ana-
lyzed on a FACScan.
DNA Fragments and Oligonucleotides.
￿
The 5'Da probe is a 1.3-
kb ECORI-Bam HI fragment mapping 5' of Dal that was isolated
from thegenomic cloneBSK61(a gift ofS. Ang, HarvardMedical
School, Cambridge, MA). All other DNA probes have been de-
scribed previously (8, 33-35). Oligonucleotides used for thePCR
were: Vat, 5'GGGGTCGACAAGTTGGTGGTCATATTA; Vat,
TGGGGTCGA000TCAGGPGCTCCATGAA; Va3, 5'000GTC-
GACACTGTATATTCAAATC; V«17 (=Va5), 5'000GTCGACT
ATACTAACAGCATGTT; Vyl, 5'TACATCCACTGGTACCTAC-
ACCAGGA; V,2, 5'GGGGTCGACCTGGTGAAGTCATACAGT
Jal, 5'GGGGAATTCCACAGTCACA000GTTC; Ja3, 5'000-
GAATTCCACGAAGAGTTTGATGCC; J,1.1, 5'000GGATCC-
AGTTACTATGAGCTTAGTCC; J,1.3, 5'G000GATCCTGTG-
ACAACAAGTGTTGT.
Preparation andBlot Hybridization of Genomic DNA and RNA.
GenomicDNAandRNAwere prepared by established procedures
(36, 37). Gel electrophoresis, blotting, hybridization with 11P-
labeled probes, and washing were as described previously (8).
Polymerase Chain Reaction.
￿
GenomicDNA(0.514g) was heated
to 94°C for7minandwas amplifiedundermineraloilfor35 cycles
in a 25 Pl reaction containing 0.2 mM each deoxyribonucleotide
triphosphate, 50 mM KC1, 1.25 mM MgCl2, 0.01% gelatin, 100
mM Tris-HCI (pH 8.3), 1 U Taq polymerase, and 20 pmol each
oligonucleotide (38). Each cycle consisted of a 0.8 min denatura-
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min. extension step at 72°C. The extension step following the last
cycle was for 9.9 min. One-fifth of each reaction was analyzed by
agarose gel electrophoresis. The remainder was extracted with chlo-
roform, phenol/chloroform (1:1), and chloroform, and was eth-
anol precipitated. Pelleted DNA was resuspended, digested using
appropriate restriction enzymes, and purified through low gelling
temperature agarose. Fragments were then cloned into appropri-
ately digested vectors prepared from Bluescript KS+ (Stratagene,
LaJolla, CA), and plasmid minipreps were prepared. When DNA
from a polyclonal cell source was amplified, secondary transfor-
mantsand minipreps were prepared in order to obtain pure clones.
Nucleotide sequences were determined on both strands by the
dideoxy chain termination method using double-stranded templates
(39) and modified T7 polymerase (40) (Sequenase; U.S. Biomed-
ical Corp., Cleveland, OH).
Stimulation of T Cell Clones and Assays for Cytokine Production.
Cellswere stimulated on day 7 after the last stimulation with feeder
cells, and were collected, spun, and then washed two times with
medium. The cells were stimulated at a concentration of 106
cells/ml per well of a 24-well plate(Linbro) . 24 h later the superna-
tant was removed, spun at 250 g, frozen, and kept at -20°C until
testing. IL4 (41), IL-5 (42), IFN-y (43), and GM-CSF (42) were
determined by ELISA as described. 11,2 levels were determined using
the IL2-dependent cell line CTLL2 as described (44).
Results
Analysis ofCellSurface Expression ofTCR-y/d on Thymo-
cyte Clones. Thymocytes of three different fetal samples were
obtained: Solo (8.5 wk of gestational age), BB (12 wk), and
CC (15 wk). Postnatal thymus samples were obtained from
two children: OM (6 mo old) and FH (4 mo old). The proce-
dures to obtain the Solo, BB, CC, and OM clones were similar.
Thymoctes were cultured in IL -2 and 11,4 for 10 d, and the
Table 1.
￿
Reactivity of Fetal and Postnatal TCR-y16 Clones with mAbs Speck for Epitopes on the Constant and Variable Regions
of the y and 6 Chains
64
35
849
￿
Krangel et al.
CD4- CD8 - cells were enriched by reversed rosetting and
cloned by limiting dilution. The FH clones were obtained
from freshly isolated purified CD3+ CD4- CD8 - cells as
indicated in Materials and Methods. To begin to investigate
the Va and V7 usage of these clones, the cells were incubated
with mAbs that recognize epitopes encoded by different V..
and Va gene segments. 9 of 15 postnatal thymocyte clones
from sample FH reacted with the 8TCS1 mAb (Table 1), in-
dicating that these clones expressed Val-ja1 determinants
(10, 45). None reacted with mAb BB3, which detects a Va2
determinant (4, 9, 46). Most of the Vat' clones were nega-
tive with the TiyA mAb, which detects a Vy2 determinant
(1), although two of the nine Vat+ clones did react with
this antibody (Table 1). One of the FH clones (FH3) reacted
with TiyA but with neither STCS1 nor BB3, and the re-
maining FH clones were negative with all of these mAbs.
Of the four OM clones, two (OM35 and OM64) reacted
with the SPCS1 mAb, and one (OM35) reacted with the TiyA
mAb. These observations confirm the findings of others that
a large fraction of postnatal TCR-y/S thymorytes are Val+,
that some of these cells coexpress Vat and Vti2, and that very
few postnatal TCR.y/S thymorytes are Va2+ (5, 6, 10, 47).
In contrast to these results with postnatal thymorytes, all
of the Solo, BB, and CC fetal thymus clones reacted with
the BB3 mAb, and none reacted with &CS1(Table 1). Most
of these were also TiyA+, indicating coexpression of Va2
and Vy2, although two of the three Solo clones (Solo 6 and
15) were TiyA- . In addition, at early stages in the expan-
sion of the polyclonal BB and CC cultures a small fraction
of the cells were BB3+ and TiyA- (data not shown), al-
though all of the clones obtained were BB3+ TiyA+ . These
data suggest that Va2 is the predominant Va gene segment
used in early fetal thymorytes, and that although V72 is also
TiyA Donor
(Gestational)
Age Clones TCR-61
Reactivity with mAbs
6TCS1 BB3
Solo (8.5 wk) 6,15
19
BB (12 wk) 2,4,5,8,10
CC (15 wk) 6,7,15,27,33,40
FH 4 mo 1,6,9,20,26
7,9,10,13,14,17,28
16,31
3
OM 6 mo 47,54used with high frequency, Vs2 usage is not strictly linked
to Vy2 usage within this cell population, despite coordinate
usage in peripheral blood (4, 8-10).
TCR-yand-6 Rearrangements in Postnatal Thymocytes.
￿
To
extend the above findings, we first analyzed the TCRy and
TCR-6 gene rearrangements and transcripts in theOM post-
natal thymocyte clones. By hybridization with aJyl.3/2.3
probe in KpnI and EcoRI digests ofgenomicDNA, and with
Vy2 and Vy3 probes in KpnI digests, we identified two rear-
rangements in each T cell clone. Some rearrangements were
further characterized by sequence analysis of PCR products
amplified from genomic DNA using V andJ specific oligo-
nucleotide primers. We found the array of rearranged V,.
gene segments to be heterogeneous, including multiple
members of the Vy1 family, as well as Vy2 and Vy3 (Table
2). Based on these results and on surface staining with the
TiyA mAb (Table 1), OM35 carries an in-frame Vy2 rear-
rangement, and OM54 and OM64 carry in-frame Vyl.4 and
Vyl.8 rearrangements, respectively. OM47 displays predom-
inantly Vyl transcripts, and therefore is likely to carry an
in-frame Vyl.3 rearrangement. Despite the observed hetero-
geneityin the rearranged Vgene segments, it is striking that
seven of the eight rearrangements in these cells involve Jy
segments upstream of Cy2, namely, Jy2.1 and Jy2.3.
Assignment of the TCR-S gene rearrangements in these
cells was accomplished by hybridization of Jal, Ja3, Vat,
Vat, 5'Da, and Vg17 probes to Xbal digests of genomic
DNA. The V.,17 probe was included because this V seg-
ment hasbeen previously mapped to the genomic region be-
tween the Val and Va2 gene segments (35). We identified
Vat rearrangements in OM35 and OM64, and a Va3 rear-
rangement in OM54. Based upon nucleotide sequence anal-
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Assignment of TCR-S gene rearrangements is according to reference 8, and assignment of TCR-y gene rearrangements is according to refer-
ences 66 and 67. Known or presumed in-frame rearrangements are in the first column, except for Solo 15, which displays two in-frame rear-
rangements. Assignments marked by an asterisk were analyzed and confirmed by PCR and nucleotide sequence analysis. The second Ja1
rearrangements in OM54 and OM64 are undefined. Sizes of the fragments detected by Jal, JO, and J,1.3/2.3 probes are in kilobases. Frag-
ments detected by other probes are either G, germline; R, rearranged; D, deleted. Germline fragments are: Ja1, 1.7 kb XbaI; Ja3, 5.4 kb
Xb2l: Jy1.3, 9.0 kb KpnI and 1.5 kb EcoRl; Jy2.3, 16 kb KpnI and 3.2 kb EcoRI.
Table 2. TCR-d and -y Gene Rearrangements in Fetal and Postnatal Thymocyte Clones
Southern
Xbal digest
Cell line Northern Jal Ja3 Val V~17 Va2 5'Da Rearrangements
Solo 6 ND - 4.4, 3.4 ND ND R,G D,G Va2 Ja3* D-DJa
Solo 15 ND 4.2 5.4, 3.4 ND ND R,R 13,13 Va2 Jsl* Va2 Ja3*
Solo 19 Va2 1.7 5.4, 3.4 G,G G,G R,G D,G Va2 Ja3* Germline
OM35 Va1 6.4 5.4 R,R D,D D,D D,D Va1 Ja1* Val Jal*
OM47 VJ7 2.9 5.4, 7.5 G,G R,G D,G D,G VXJa3* D-DJal
OM54 Va3 3.9, 1.9 5.4 G,G G,G D,G D,G Va3 Jal* Ja1
OM64 Val 6.4, 3.2 5.4 R,G D,G D,G 13,13 Val Jal* Jal
Southern
KpnI
J,1.3/2.3
digest
V,2 V,3
EcoRl digest
J,1.3/2.3
Solo 6 ND 16, 14, 8.5 R,D D,D 3.2, 1.5 V,,1.8J,1.1' V,2 J,1.1'
Solo 15 ND 16, 8.5 D,D D,D 3.2, 1.5 V,1.8J,1.1* V,1.8J,1.1'
Solo 19 V,2 16, 9.0, 7.9 R,G D,G 3.2, 2.3, 1.5 V,2 J,1.3" Germline
OM35 V,2 7.6, 7.2 R,R 13,13 2.3, 1.8 V,2 J,2.3 V,2 J,2.3
OM47 V,1 16, 5.0, 1.8 D,G R,D 5.0, 3.2 V,1.3J,1.3 V,3 J,2.1
OM54 V,1 7.6, 1.8 R,D D,D 2.3, 0.9 V,1.4J,2.3* V,2 J,2.3
OM64 V,1 5.0, 1.8 D,D D,D 4.0, 3.2 V,1.8J,2.3 V,1.8-J,2.1 *A
A L G D H
￿
L A
￿
T G V Q
￿
Y T D K L
TGCTCTTGGGGA
￿
TCA
￿
CCT
￿
GGC
￿
T ACTGGGG
￿
TACA
￿
GT ACACCGATAAACTCA
G E L
￿
I L P V
￿
Y W G T F L C t P i
GGGGAACT
￿
TATT
￿
CTTCC
￿
CGTC
￿
T ACTGGGGGA
￿
CTTTTCTCT
￿
GT ACACCGAT
V65/VQ17 N
￿
062 P N D63
￿
N
￿
J63
C A A 5 A L P T
￿
R R I R D R D W D
TGTGCAGCAA
￿
GCGCG
￿
CTTCCTAC G
￿
ALGA
￿
GGATACG
￿
GGATCGGGA
￿
CTGGGAC
s
V OM47
117 VQ
V65
VQ17 .1
V ON47
L17 Va
V65
VQ17 .1
OM35
Val
￿
N Dal N P D63 N P
￿
J61
Val N Dal N P D63 N P Jal
OM47
OM54
V63
￿
N P D82 N
￿
J61
T Y Y C A L G F G L P I I
￿
E L I F G K
ACTTACTACTGTGCC
￿
CTCGGATTC
￿
GG CCTTCCTA
￿
TCATTG
￿
AACTCATCTTTGGAAAA
OM64
Val N Dal N D63
￿
N P Jal
G E L H L L N W G I F A L E
￿
Y T D
GGGGAA
￿
TTACAT
￿
CTT
￿
TTGA
￿
ACTGGGGGATA
￿
TTTGCCCTGGA
￿
GT ACACCGAT
TATACTAACAGCATGTTTGATTATTTCCTATGGTACAAAAAATACCCTGCTGAAGGTCCTACATTCCTGA
---------------------------- -----------------------------------
----------------------------------------------------------------------
V OM47
￿
TATCTATAAGTTCCATTAAGGATAAAAATGAAGATGGAAGATTCACTGTTTTCTTAAACAAAAGTGCCAA
L17 VQ ￿----__----__----___----__---___----__---___------C---__--___---___----
V65 __---___---____---____--___---_____--___----__---C___--__---____--____
Va17 .1 ___---____--_ .___--____---___----------__----___---CT---__----___--___
GCACCTCTCTCTGCACATTGTGCCCTCCCAGCCTGGAGACTGCAGTGTACTTCTGTGCAGCAA
---------------------------------------------- -----------
---------------------------------------------- ----------- -----------
-----------CATG----___----__----__----__----__-----__----_,--__
Figure l .
￿
Nucleotide sequence analysis of TCR-S gene rearrangements
in postnatal thymocyte clones. (A) functional sequences were deter-
mined from PCR products amplified using appropriate pairs of
primers. D elements were assigned with the requirement for a mini-
mum of three contiguous matches to the germline sequence. P nu-
cleotides were assigned according to reference 19. Deduced amino
acid sequences are in the single letter code; a shift to lowercase letters
indicates a shift to an inappropriate reading frame. (B) The nucleotide
sequence of the amplified portion of the OM47 V segment is com-
pared with the analogous portions of three previously reported V se-
quences: L17 Vim, (48), V65 (50), and V.17.1 (49). The VOM47 se-
quence was confirmed using multiple DNA templates. Differences
between this sequence and the published sequences are noted.
ysis of VDJ junctional regions amplified by PCR, one of
the two Vs1 rearrangements in OM35, as well as the V63
and Va1 rearrangements in OM54 and OM64, respectively,
are in-frame (Fig. 1 A).
Analysis of both Northern and Southern blots using the
V,,17 probe revealed the rearrangement of V.17 or a highly
homologous V segment to Jai in OM47. The nucleotide se-
quence ofthe VDJjunction of this rearrangement following
PCR amplification (Fig. 1 A) demonstrated it to be in-frame.
The sequence of a portion of the rearranged V segment is
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compared with three other closely related sequences in Fig.
1 B. The VOM47 sequence differs from the previously de-
scribed L17 V« (48) cDNA sequence by a single nucleotide,
and from the previously described Vg17.1 (49) sequence by
six nucleotides. Furthermore, a recently identified Va seg-
ment denoted Vas (50) also differs from the VOM47 se-
quence by a single nucleotide, and is identical to L17 V,,,.
Since an L17 V« probe detected only a single hybridizing se-
quence on Southern blots (data not shown), the different se-
quences must represent polymorphic variants of the same V
gene segment. Thus, this V segment, which maps to the
proximal portion of the human TCRa/S locus, can rear-
range to both Da and J,,, segments, and thereby serves as
both a Va and a V,,, .
The analysis of a truncated cDNA clone representing the
3 .9-kb Jal rearrangement in OM54 revealed an out-of-frame
rearrangement involving a previously undescribed V segment
that maps between V~17 (=VaS) and Va2 (data not shown).
The 3.2-kb J6 1 rearrangement in OM64 was not charac-
terized.
TCR--y and -S Gene Rearrangements in Early Fetal Thymo-
cytes. We next analyzed the TCR--y and -S gene rearrange-
ments in the 8.5-wk fetal thymus clones Solo 6, 15, and 19,
and found them to be strikingly different from those observed
in the postnatal thymocyte clones (Table 2). Southern blots
revealed the rearrangement of both Vy2 and Vyl gene seg-
ments. Notably, all five TCR--y rearrangements were found
to involve the Jyl, rather than the Jy2 cluster, whereas one
chromosome was in the germline configuration. To identify
the rearranged Vy1 gene segments, each VJ rearrangement
was amplified by PCR usingan oligonucleotide that anneals
to all Vyl sequences as a 5' primer, and aJy1.1 oligonucleo-
tide as a 3' primer. Nucleotide sequence analysis indicated
the rearrangement of V.y1.8 in every instance and showed
that Solo 6 and Solo 15 each carry a single in-frame Vy 1.8
rearrangement (Fig. 2). Similar PCR analysis revealed the
Vy2 rearrangement in Solo 19 to be in-frame, and that in
Solo 6 to be out-of-frame (Fig. 2), in accordance with staining
results (Table 1) .
Together with the staining analysis of the Solo, BB, and
CC clonal and polyclonal lines (Table 1), the above results
indicate that whereas Vy2 rearrangements are common in
early fetal thymocytes, Vyl rearrangements occur as well.
Further, these results suggested that the rearrangement of
V.y1 gene segments in early fetal thymocytes might not be
random. To specifically address this issue, we analyzed DNA
prepared from polyclonal BB and CC cultures by PCR using
V .,1 and JyM primers. Six of six clones sequenced that were
obtained following amplification of BB DNA used V.Y1.8
(Fig. 3). Two of four clones obtained following amplification
of CC DNA used V.J.8, whereas one clone each used Vy1.3
and VJ.4. All clones were independent based upon their VJ
junction nucleotide sequences. Further, 8 of 10 were out-of-
frame, in accordance with staining data indicating the BB
and CC cultures to be composed primarily of TiyA+ TCR
y/S lymphocytes and TCR-oi/a lymphocytes. These results
provide strong evidence that Vyl rearrangements in early
fetal thymocytes involve Vyl.8 almost exclusively, at leastFigure 2.
￿
Nucleotide sequence analysis of TCR-6 TCR-y gene
rearrangements in fetal thymocyte clones. functional sequences were
determined from PCR products .amplified using appropriate pairs of
primers. They are compared with the relevant germline gene segment
sequences (underlined). All sequences were confirmed using multiple
DNA templates. The Vy segments involved in all three rearrange-
ments amplified using Vyl and Jyl.l primers could be assigned as
Vy1.8 based on a comparison of the sequences determined 5' of the
junctional region with those reported in reference 12 (see for example
Fig. 3).
Figure 3.
￿
Nucleotide sequence analysis of Vyl rearrangements in
polyclonal 12- and 15-wk fetal thymocytes. functional sequences were
determined from PCR products amplified using Vyl and Jy1.1
primers. They are compared with the germline V y1.8 and Jy1.1 se-
quences (12, 67), with differences noted. Vy assignments along the
left border of the figure are based upon comparison to the reported
V. yl.l--V y1.8 sequences (12). The single nucleotide substitution in one
putative Vy1.8 sequence is most likely a mutation introduced during
PCR amplification because this substitution is not found in any
known Vyl sequence. Sequences are classified as either in-frame (+)
or out-of-frame (-) along the right border.
through fetal week 12. This result is striking since Vy1.8 lies
at the end of the Vy1 cluster that is proximal to V y2.
Analysis of TCR-6 rearrangements in the Solo clones re-
vealed the Vat gene segment to be the only V6 segment
rearranged in these cells (Table 2). Solo 15 displays two V62
rearrangements and Solo 19 displays a V62 rearrangement
on one chromosome and retains the germline configuration
on the other chromosome. Solo 6 displays one V62 rear-
rangement and on the other chromosome displays a previ-
ously uncharacterized 4.4-kb rearrangement detected by the
J63 probe in an XbaI digest. We conclude that this rep-
resents a partial rearrangement (D-J or D-DJ) involving J62
for the following reasons: First, the genomic region hy-
bridizing with the 5'D6 probe has been retained on one
chromosome, arguing that on this chromosome rearrange-
ment has not proceeded 5' of D61. Second, the intensity of
hybridization ofthe rearranged fragment is equivalent to germ-
line as assessed with a J63 probe; since the probe straddles
J63, hybridization is significantly diminished upon rearrange-
ment of Jai, but not J62. Finally, although the V63 gene
segment maps 3' of C6 and would not delete the region hy-
bridizing to the 5'Da probe upon rearrangement, the pre-
dicted size of a V63J62 rearranged fragment is only 3.3 kb.
The VDJ junctional regions of the V32 rearrangements
in these cell lines were amplified by PCR and their nucleo-
tide sequences were determined (Fig. 2). Notably, all four
rearrangements were found to be functional. Solo 15 there-
fore displays two in-frame rearrangements, and possibly two
y/6 TCRs on its cell surface. This apparent violation of al-
lelic exclusion could have arisen if the two rearrangements
occurred nearly simultaneously. However, it is intriguing that
other reports have suggested that allelic exclusion at the TCR
a .locus may not be complete (51-53). Nevertheless, these
data, alongwith the results of surface staining (Table 1), argue
that V62 rearrangements predominate in early fetal thymo-
cytes, even though, as demonstrated in this and in other studies,
they are rare in postnatal thymocytes (5, 6, 10, 47).
Minimal Diversity ofEarly Fetal Thymo to TCR-y and -a
V-(D}Jfunctions. A striking feature of the TCR-y and -8
junctional sequences presented in Fig. 2 is the limited diver-
sity they display relative to the junctions of rearrangements
in postnatal thymocytes (Fig. 1 A) (47) and peripheral blood
lymphocytes (7, 8, 34, 47) . Two of the five TCR y VJjunc-
tions analyzed display no incorporation oftemplate indepen-
dent N-region nucleotides, and a total of only six N-region
nucleotides are seen in the fivejunctions analyzed. The TCR6
VDJ junctions are even more striking. They reveal only two
N-region nucleotides among the four sequences, with three
of the junctions displaying no N-nucleotide incorporation.
Further, the only Da segment used is D63. Hence, these
VD-Jjunctional sequences bear marked similarities to those
described for TCR-S gene rearrangements in very early mu-
rine fetal thymocytes: the use of a single V gene segment,
the use ofonly the 3' D gene segment, and minimal N nucleo-
tide incorporatipn (16-19).
To confirm and extend these findings, we analyzed thejunc-
tions o£;Va2 rearrangements in the polyclonal BB and CC
fetal thymocyte cultures. Southern blot analysis of Xbal
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V62 N D63 N P J61
GERMLINE : TGTGCCTGTGACACC ACTGGGGGATACG ACACCGATAAAC
C A C D T G G Y T D K
SOLO 15(1) : TGTGCCTGTGACACC GGGGGAT ACACCGATAAAC
J63
GERMLINE : CTCCTGGGACAC
C A C E V G D T S W D T
SOLO 15(2) : TGTGCCTGTGA GG TGGGGGATAC CTCCTGGGACAC
C A C D T G G Y S W D T
SOLO 6 : TGTGCCTGTGACACC GGGGGATA CTCCTGGGACAC
C A C D W G S S W D T
SOLO 19 : TGTGCCTGTGAC TGGGGGA G CTCCTGGGACAC
Vy 1 .8 N Jy 1 .1
GERMLINE : TCTATTACTGTGCCACCTGGGATAGG ATACCACTGGTTGGTTCAAGAT
V Y Y C A T W D N W F K I
SOLO 15(1) : TCTATTACTGTGCCACCTGGGATA A TTGGTTCAAGAT
V Y Y C A T C G 1 w 1 v q d
SOLO 15(2) : TCTATTACTGTGCCACCTG TGG CCACTGGTTGGTTCAAGAT
V Y Y C A T W D T T G W F K I
SOLO 6(1) : TCTATTACTGTGCCACCTGGG ATACCACTGGTTGGTTCAAGAT
V y2
GERMLINE : CCTACTACTGTGCCTTGTGGGAGGTG
T Y Y C A L W E V y h w 1 v q d
SOLO 6(2) : CCTACTACTGTGCCTTGTGGGAGGT ATACCACTGGTTGGTTCAAGAT
GERMLINE : GAATTATTATAAGAAACTCTTT
T Y Y C A L W E M N Y Y K K L F
SQLO 19 : CCTACTACTGTGCCTTGTGGGAG AT GAATTATTATAAGAAACTCTTT
YT 1 .8
GERMLINE ; §rpnAeTCT0 . TTCeACCTCA[TCTC[E[TCTATTACT[T[C[ACCTCCL°TA[[
FETAL WK 12 (BB)
N il l . I
ATACCACTGGTTGGTT
V T ! .B C----------------------- A
V T1 .8 ------------------ ------------------ CRAG
VT1 .8 ------------------ ------------------ ----------------------
VT1 .8 ----------- - CAGG
V T 1 .8 ---------- -- -------- ------------------------- TT
YT1 .8 ---------------------------------------- CGGGGA ------------
FETAL WK 15 (CC)
. . .------------------------------------------------ __
CAGG
C
-------------
----
-CG_____I._____ . .-A---- - .________ . . .-___G_ : TT __ .__
Vy 1 .3 _[_AA___T--------------------------- __[__- ____ ._____ ._ .digested BB and CC genomic DNA using a radiolabeled
Vat probe revealed that in both populations Vat rearrange-
ments to Ja3 predominated over those to Jal (data not
shown). We then used PCR to amplify both types ofjunc-
tions in each sample. The analysis of 13 junctions of 12-wk
fetal thymocytes and 17 junctions of 15-wk fetal thymocytes
is presented in Fig. 4. All 30 junctions display portions of
the Da3 gene segment. By contrast, only three display pos-
sible contributions from Dal, and two from Dal. However,
sincein these instances the maximal contribution is only three
nucleotides, apparent Dal and Da2 contributions could have
arisen by chance. We conclude that Dal and Da2 rearrange-
ments are rare events in early fetal thymocytes.
These junctions also display minimal incorporation of
N-region nucleotides. Roughly one-third of the 12-wkjunc-
tions, and one-half of the 15-wk junctions, display no N
nucleotides. The average number of N-nucleotides perjunc-
tion increases from 0.5 at 9 wk to 2.4 at 12 wk and 2.7 at
15 wk. When only N-nucleotide positive junctions are con-
sidered, these numbers increase to 2.0 at 9 wk, 3.7 at 12 wk,
and 5.4 at 15 wk. By contrast, the sequences offive different
Va
￿
P N
￿
Dal
￿
M
￿
P
￿
Da2
￿
P
￿
N
￿
P
￿
Da3
￿
P
￿
N
￿
P
￿
is
GERNLINE :
1 GGAACT
￿
GAAATAGT
￿
CCTTCCTAC
￿
ACTGGCf,GATACG
￿
ACACCGATAA I
2 GACACC
￿
CTCCTGGGAC 3
3 CMAG
S CAGCAA
FETAL WK 8 .5 (SOLO)
Figure 4.
￿
Nucleotide sequence analysis of TCR-S rearrangements in
polyclonal 12- and 15-wk fetal thymocytes. functional sequences were
determined from PCR products amplified from BB and CC DNA
using appropriate pairs of primers. They are compared with germline
sequences (top), fetal thymocyte clone sequences (Solo, Fig. 2), and
postnatal thymocyte clone sequences (OM, Fig. 1 A). Numbers along
the left border denote the Va segment used (Va1,2,3,5) and those
near the right border denote the Ja segment used (1x1,3). Sequences
are classified as either in-frame (+) or out-of-frame (-) along the
right border.
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junctions from the OM postnatal thymocyte y/S T cell clones
(using Vat, Va3, and Va5) reveal in most instances the usage
of both Da3 and Dal, and display much more extensive
N-nucleotide incorporation (15.8 per VD-DJjunction) (Figs.
1 and 4).
To determine whether the differences notedbetween early
fetal and postnatal thymocyte TCR-S junctions are related
to the age of the sample rather than the particular V gene
segment rearranged, we amplified by PCR a single rare ex-
ample of Val to Ja3 rearrangement in each of the polyclonal
fetal thymus samples (Fig. 4). Bothjunctions display the use
of only the DO gene segment, and display no N-nucleotide
incorporation. These data therefore argue that TCR-S junc-
tional diversity increases in an age-related fashion throughout
early thymic development, and is only indirectly associated
with V segment usage.
Cytokine Production by Fetal and Postnatal TCR-ylb Thymo-
cyte Clones. In order to reveal possible functional differences
between the Va2+ fetal and Vat - postnatal thymocyte
clones, we analyzed the capacity of the clones to produce
cytokines upon stimulation. Therefore the clones were stimu-
lated with 30 14g/ml ConA, a powerful polyclonal stimulant
for human T cell clones (54), and the supernatants were as-
sayed for 11,2, ID4, IM, IFN-y, and GM-CSF. Table 3 shows
the cytokine production profiles of seven fetal TCRy/S clones
from samples Solo, BB and CC, and seven postnatal TCR-
,y/S clones from donors OM and FH. All fetal clones pro-
duced significant levels of ID4 after activation with ConA.
The fetal clones also produced 11,5 and high levels of GM-
CST and IFN-y. Three additional fetal clones also produced
I1r4 and M after activation, but one (CC40) consistently
failed to produce 11,4 or IM, and secreted low levels ofGM-
CSF but significant amounts of IFN-y (data not shown). In
contrast to the fetalclones, the clones derived from postnatal
thymic material did not produce IIr4 or 11,5 above background
(Table 3). In general, the clones produced less GM-CSF than
the fetal clones, although the levels of lL2 and IFN-y were
comparable (Table 3). The same pattern of cytokine produc-
tion was observed with five other postnatal TCRy/S thymo-
cyte clones (data not shown).
To determine the capacity of these clones to produce
cytokines afteractivation via the TCR/CD3 complex or CD2,
they were stimulated with a CD3 mAb in the presence or
absence of the phorbol ester PMA or by a mitogenic combi-
nation ofanti-CD2 mAbs. As a control, the clones were stimu-
lated with PMA alone, a treatment that normally cannot ac-
tivate mature T cells on its own (54). The cytokine production
pattern of three representative fetal and three postnatal TCR-
y/S clones is presented in Table 4. The combination of anti-
CD2 mAbs was able to induce cytokine production in all
clones. As expected, the anti-CD3 mAb SPVT3b only in-
duced cytokine production in combination with PMA. In-
terestingly, PMA alone activated the cells to produce cytokines.
Whereas 1 ng/ml PMA was sufficient to trigger secretion
of significant levels of cytokines (data not shown), 10 ng/ml
was found to be optimal. The patterns of cytokine produc-
tion after activation via CD2 or TCR/CD3 were the same
as after activation via ConA, inasmuch as the fetal thymo-
2 GAMC G
2 GACA
2 GACACC
2 GA
1 GGAA
FETAL WK 15 (CC)
2 GA AC MT
C
T
CTGGGGGGATACG CTCCTGGGAC 3 +
T ACTGGGGGATACG ACT TGGGAC 3 +
GGGATACG TA CTGGGAC 3 +
T ACTGGGGGATACG G CTGGGAC 3 +
GGGGGATA CTCCTGGGAC 3 +
T ACTGGGGGAT ACACCGATAA I +
2 GAC TGGGGGAT ATM 1 -
2 GACAC TGGGGGAT ACACCGATM 1 +
2 GACAC GGC GGGATA CGATAA 1 +
2 GAC GCGCC T ACTGGGGGATACG CG AAAGGGG G CTCCTGGGAC 3 +
2 GACACC GGGG TC AS CTOCTGGGAC 3 +
2 GACACC G CA GGGGG CTCCTGGGAC 3 +
2 GACACC ACTGGGGGATA CTCCTGGGAC 3 +
2 GACACC TGGGGG TC CTCCTGGGAC 3 +
2 GALA AAA T ACTGGGGGATAC CTGGGAC 3 +
2 GACAC TGGGGGATA CTGGGAC 3 +
2 GACACC G TAAG TGGGGGATACG C TC CCTGGGAC 3 +
2 GACACC GA GGGG TCACGGTC CCTGGGAC 3 -
2 CAC CGG GT ACTGGGGGAT CGG AG CTCCTGGGAC 3 +
2 GACACC GGGGGATA CTCCTGGGAC 3 +
2 GACA GA GT ACT000 ACAA AG CTCCTGGGAC 3 +
2 GACACC G CTGGGGGATA CTCCTGGGX 3 +
1 GGAA T ACTGGGGGATACG CTCCTGGGAC 3 +
POSTNATAL (ON)
1 GGAACT TATT CTTCC GTC T ACTGGGGGA CTTFTCTCT GT ACACCGATAA I -
I GGA TCA CCT GGC T ACTGGIYG TACA GT ACACCG4TM 1 +
1 GGAA TTACAT CTT TTGA ACTGGGGGATA MGCCCTCGA GT ACACCGATAA I +
3 C CTCGGATT GG CCTTCCTA TCATTG A 1 +
5 CAGCAA GCGCG CMCTAC G AGrA GGATACG GGATCGGGA CTGGGACA 3 +
2 GACACC
2 GACACC
2 GA
2 GNC
FETAL WK 12
2 GAC
(BB)
GG
GGGGGAT
GGG .GATA
TGGGGGATAC
TGGGGGA
ACTGGGGGATACG
ACACCGATAA 1 +
CTCCTGGGAC 3 +
CTCCTGGGAC 3 +
G CTCCTGGGAC 3 +
CCGATAA 1 +
2 ACTGGGGGATAC CGATAA 1 +
2 k kACC ACC G TC GGIY.GAT CGGTTG G CTCCTGGGAC 3 +
2 GACACC TGGGGGA G CTCCTGGGAC 3 +
2 GACACC TGGGGGATA CCTGGGAC 3 -
2 GACACC G CGCA GGGATAC AG CTCCTGIYAC 3 +
2 G CCT GTT T ACTGGGGGATA G CTCCTGGGAC 3 +
2 GACACC G CTA GGGGATACG CG AG CTCCTGGGAC 3 +
2 GAC G TAG CT GMT M CTCCTGGGAC 3 +Each value is the mean ± SD of duplicate determinations . One of three representative experiments is shown. Cytokine production varied
quantitatively, but not qualitatively, between experiments:
cytes produced 11,4 and Ilr5, whereas the postnatal thymo-
cytes secreted at most only very low levels of these cytokines
(Table 4).
Discussion
By analyzing the rearrangement and expression of the
TCRy and -6 genes in early human fetal thymocytes we have
obtained strong evidence that rearrangement at these loci
occurs in an orderly and coordinated fashion, summarized
schematically in Figure 5 . Our data indicate that the initial
rearrangement events at the TCR-6 locus involve thejoining
of the Vs2 gene segment to the DO gene segment. The ini-
tial rearrangement events at the TCR-y locus involve the
joining of downstream Vy gene segments, primarily Vy1.8
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and Vy2, to Jy gene segments of the Jyl cluster. At later
times there is a switch in the rearrangement pattern at the
TCR-6 locus such that the Vs1 gene segment (as well as
some other Vs gene segments), is joined primarily to the
upstream Ds gene segments, Ds1 and Ds2. Similarly, there
is a switch in the rearrangement pattern at the TCRy locus
such that upstream Vy gene segments in the Vyl family are
joined to downstream Jy gene segments of the Jy2 cluster.
Superimposed on this highly ordered rearrangement pattern
is a gradual increase in diversification at thejunctions of the
rearranged gene segments through the incorporation of
template-independent N region nucleotides. Our results are
almost certainly due to control at the level of gene rearrange-
ment rather than to selection based upon surface TCR ex-
pression, since the out-of-frame rearrangements that were ana-
Lymphocytes in the Early Fetal Thymus
Table 3 . Cytokine Production by Fetal and Postnatal Thymocyte TCR-y/6 Clones Stimulated with 30 #g/ml ConA
Clone ConA IL-2 IL-4 IL-5 IFN--y GM-GSF
U/ml pg/ml pg/ml ng/ml ng/ml
Solo 6 - <0 .5 <50 ND <0.3 <0.05
+ 4.0 2,397 ± 289 ND 125±3 22±3
Solo 15 - <0 .5 <50 <50 <0.3 <0.05
+ 10.0 200 ± 27 796 ± 102 25 ± 4 16 ± 1 .3
Solo 19 - <0.5 <50 <50 <0.3 <0.05
+ 6.7 496 ± 104 575±43 89±3 26±9
BB2 - <0 .5 <50 <50 <0 .3 <0.05
+ 6.5 1,658 ± 108 270 ± 39 220 ± 57 >20
BB5 - <0.5 <50 <50 <0 .3 <0.05
+ 5.0 502 ± 100 542 ± 88 110 ± 16 23 ± 7
CC6 - <0.5 <50 <50 <0.3 <0.05
+ 9.6 1,096 ± 31 1,540±500 81±8 19±3
CC7 - <0.5 <50 <50 <0.3 <0.05
+ 8.0 286 ± 9 96±20 121±25 2±0.2
OM35 - <0.5 <50 <50 <0.3 <0.05
+ 4.3 <50 <50 18±5 2.5±0.8
OM47 - <0.5 <50 <50 <0.3 <0.05
+ 3.9 <50 <50 10±3 0.5±0.02
OM64 - <0.5 <50 <50 <0.3 55 ± 6
+ 5.0 <50 <50 50 ± 0.1 10 ± 0.4
FH3 - <0.5 <50 <50 <0.3 <0.05
+ 9.3 <50 <50 83±0.3 3±0.5
FH13 - <0.5 <50 <50 <0.3 <0.05
+ 4.6 <50 <50 37±0.1 5±0.9
FH26 - <0.5 <50 <50 13 ± 0.1 <0.05
+ 9 .6 <50 <50 68±0.3 5±0.5
FH31 - <0.5 <50 <50 <0.3 <0.05
+ 7.3 <50 317±72 21±2.6 1±0.03Table 4.
Clone
BB2
BB8
BB10
FH3
FH13
FH26
7 d after the previous stimulation, cells were washed twice and stimulated at a concentration of 106 cells/ml with a combination of 1 tzg/ml
purified SPV-T3b (70) and 1 ng/ml PMA, 10 ng/ml PMA, or a 1:2,500 dilution of ascites of the anti-CD2 mAbs X.11-1 and D66 (71).
Each value is the mean ± SD of duplicate determinations. One of three representative experiments is shown.
lyzed displayed properties that were highly similar to the
in-frame rearrangements.
Previous studies have shown that the predominant popu-
lation of TCRy/S lymphocytes in human peripheral blood
displays cell surface TCRs that pair TCR 6 chains using Vs2
with TCR y chains using Vy2-Cyl (4, 8-10). We have pre-
viously demonstrated in transfection experiments that there
is no physical barrier that prevents Vs2+ TCR 6 chains from
pairing with Vyl-Cy2 TCR y chains (46). Consistent with
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this result, and the recent analysis of a large panel of post-
natal thymocyte clones (10), we find that two of three early
thymocyte clones display cell surface TCRs composed of
Vs2+ TCR 6 chains paired with Vyl.8-Cyl TCR y chains.
We therefore suggest that the predominant Vs2/Vy2-Cyl
peripheral blood population arises as the result of two dis-
tinct processes. Coordination between rearrangement events
at the TCR-y and -6 loci as described here dictates that TCR
y1b lymphocytes that use Vs2 will also express TCR y
Cytokine Production by Fetal and Postnatal Tbymocyte TCR-y/d Clones after Activation via CD3 or CD2
Stimulus IL-2 IL-4 IL-5 IFN--y GM-CSF
U/ml Pg/ml Pg/ml ng/ml ng/ml
- <0.5 <50 <50 <0.3 <0.05
ciCD2 2.0 400 ± 3 389±39 27±4.4 3.4±0.3
ciCD3 <0.5 <50 <50 <0.3 <0.05
PMA 0.9 <50 550±160 5±0.06 2.1±0.2
aCD3 +PMA 5.5 538 ± 16 1,072 ± 180 93 ± 0.4 61 ± 14
- <0.5 <50 <50 <0.3 <0.05
aCD2 7.6 1,814 ± 22 7,020 t 2,670 39 ± 0.2 23 ± 6.9
oiCD3 <0.5 <50 <50 <0.3 <0.05
PMA 0.9 <50 622 t 218 6 ± 0.1 2.1 ± 0.1
otCD3+PMA 4.2 203 ± 10 3,034 ± 24 38 ± 8 5.4 ± 1.7
- <0.5 <50 <50 <0.3 <0.05
aCD2 28.2 1,270 ± 50 5,104 ± 1,048 38 ± 3 27 ± 0.5
ceCD3 <0.5 <50 <50 <0.3 <0.05
PMA 1.5 <50 4,452±460 14±6 1.8±0.1
aCD3 +PMA 4.0 678 ± 118 >10,000 38 ± 9 12.2 ± 0.3
- <0.5 <50 <50 <0.3 <0.05
ceCD2 4.5 <50 <50 93 ± 3.8 93 ± 0.6
ciCD3 <0.5 <50 <50 <0.3 <0.05
PMA <0.5 <50 <50 26±0.6 2.4±0.2
ceCD3 + PMA <0.5 <50 <50 55±3 1.2±0.03
- <0.5 <50 <50 <0.3 <0.05
aCD2 11 .0 <50 176 ± 55 30 ± 0.2 2.4 ± 0.4
aCD3 <0.5 <50 <50 <0.3 <0.05
PMA <0.5 <50 <50 <0.3 1.8 ± 0.02
ceCD3 +PMA <0.5 <50 <50 40± 1.6 0.7±0.1
- <0.5 <50 <50 <0.3 <0.05
aCD2 1.0 <50 <50 11±0.5 1.2±0.1
ceCD3 <0.5 <50 <50 <0.3 <0.05
PMA <0.5 <50 <50 52±0.1 2.3±0.1
aCD3 +PMA 1.0 <50 <50 32 ± 11 1.2 ± 0.05_.~ r-
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Figure 5.
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Controlled and coordinate TCR--y and TCR-b gene rear-
rangement. TCR-.y locus organization is according to references 66
and 72. Open boxes represent nonfunctional pseudogenes. TCR-6
locus organization is according to references 8, 35, and 47. The pre-
dominant early fetal (early) and postnatal (late) rearrangement pat-
terns are depicted.
chains using downstream Vy segments (Vyl .8, Vy2, etc.)
along with C,-,l. However, among these TCR y chains, only
those that use Vy2 are detected at significant levels in pe-
ripheral blood. Further, Vy2-Ctrl chains preferentially use
Jyl.2 (1, 8, 10). These observations argue that selection must
also play an important role in generating this specific cell popu-
lation. In this regard, it is important to note that Parker et
al. (55) have recently provided evidence for postnatal, extra-
thymic expansion of the V62/Vy2-C7 1 subset.
Although we do not have formal evidence that the early
fetal thymocytes analyzed in this study include the precursors
of the predominant V62/Vy2-Cyl population in adult pe-
ripheral blood, a number of observations argue that this is
probably the case. A comparison ofour data on fetal and post-
natal thymocyte TCR S VDJ junctions to similar data ac-
cumulated from peripheral blood TCR-,y/S lymphocytes
argues that the V61+ and V62+ subsets arise via rearrange-
ments occurring at distinct phases of thymic ontogeny. Pe-
ripheral blood and postnatal thymocyte V61 junctions typi-
cally display contributions from multiple D6 segments,
rather than solely from D63, and display extensive N-nucle-
otide incorporation (this study; 34, 47, 50). By contrast, the
peripheral blood V62 junctions are generally less complex,
often displaying a contribution from only D63, and less ex-
tensive N-nucleotide incorporation (7, 8, 50). Further, J63
usage, which apparently predominates in early fetal thymo-
cytes, is much higher in the peripheral blood V62+ subset
than in the peripheral blood V61 + subset (8, 10, 34). Taken
together, these observations suggest that a significant frac-
tion of the V62/Vy2-Cyl lymphocytes in peripheral blood
are generated relatively early during thymic ontogeny.
Whether a subset of the early fetal thymocytes also serves
as the precursor of a population of human TCR-y/b lym-
phocytes with a distinct anatomical localization cannot be
eliminated, however.
Our data demonstrate remarkable similarities between the
earliest rearrangement events at the human and murine TCRy
and -b loci. In both systems the repertoire of rearrangeable
V gene segments is initially highly restricted, and the usage
of homologous D6 gene segments (D63 in the human, D62
in the mouse) and J6 gene segments U63 in the human, J62
in the mouse) predominates (16, 18, 19). Further, junctional
diversification by the incorporation of N-region nucleotides
is minimal or absent in both systems at early times, presum-
ably as the result oflow levels ofterminal transferase activity
(56). However, the analysis of the V(D)J junctions of early
murine fetal thymocytes that use specific pairs of V7 and V6
gene segments has also shown them to be highly homoge-
neous, and to encode the TCRs expressed on adult lympho-
cytes in certain epithelial locations (19-22). In marked con-
trast, the V62-D63-J63 junctions analyzed here are quite
heterogeneous. Thejunctions of the Solo clones were all dis-
tinct, and did not match any of thejunctions obtained from
the polyclonal BB and CC cultures. None of the CC junc-
tions occurred more than twice among the sequences exam-
ined, and although one BB junction was detected at high
frequency, it seems most plausible to attribute this result to
oligoclonality as the result of expansion of the BB culture
in vitro. These results would argue that early human TCR-
,y/b lymphocytes might not be subjected to the same types
of intrathymic selection that limit the repertoire of certain
intraepithelial lymphocytes in the mouse (19-22).
Striking differences were found in the capacities of fetal
and postnatal TCRy/b thymocytes to produce cytokines upon
activation, suggesting that these two sets ofTCR-y/b thymo-
cyte clones represent functionally distinct subpopulations. In
contrast to postnatal TCR-7/6 thymocyte clones, the fetal
clones produced significant levels of IL4 and IL-5 after acti-
vation with either the lectin ConA, anti-CD3 mAb plus PMA,
or a mitogenic pair of anti-CD2 mAbs. Both sets of clones
were able to secrete GM-CSF and IFN-.y. The failure ofpost-
natal TCR--y/S thymocyte clones to produce 11,4 is probably
due to a lack of11,4 gene transcription, because with a highly
sensitive PCR technique no IL4 mRNA could be detected
after activationofthe clones with ConA (De Waal Malefyt, R.,
and H. Spits, unpublished data). Since the postnatal and fetal
clones were cultured under identical conditions, the inability
of the postnatal clones to produce 11,4 and IL5 is not ac-
quired in vitro. Moreover, freshly isolated day 13-15 murine
CD3+ fetal thymocytes that contain only TCR-y/b cells
produce 114 upon stimulation with anti-CD3 mAb (57).
We believe, therefore, that the fetal TCR-y/b cells have the
ability to produce 114 and 1175 in vivo. The cloned TCR-
y/b lines produced cytokines upon activation via the
CD3/TCR-y/b complex or via CD2, but whether or not
TCR-y/b cells are actually stimulated in vivo to produce IL4
and 11,5 is unknown. In situ hybridization should be carried
out to investigate this point.
TCR-y/b thymocytes might play a role in early TCR-ct/(3
T cell development, and if so, cytokines are presumably in-
volved. Our data could therefore be an indication that IL4,
IL-5, or both, are important regulators of early thymic devel-
opment. In man, the main target cell of 11,5 is the eosino-
Human T Cell Receptor -y/6 Lymphocytes in the Early Fetal Thymusphil (58). In addition, some effects of IIr5 on human B cells
have been documented (58, 59), but so far no effects of IIr5
on human T cells have been reported. It is therefore unclear
what the biological significance is of IM for thymic devel-
opment. On the other hand, T cells can respond to 11,4. While
activated mature human T cells proliferate in response to IIr4
(60), this factor can inhibit activation of resting human T
cells under certain conditions (61) . In the mouse, CD4-
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cytes cultured for 14 d in IIr4 contain an elevated percentage
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